ZELTIQ Aesthetics Wins Major Legal Decision in Europe


28.05.13 22:35
Meldung
 
(Nasdaq:ZLTQ), a medical technology company focused ondeveloping and commercializing products utilizing its proprietarycontrolled-cooling technology platform, today announced that it prevailed in amajor legal case. On May 23, 2013, the Tribunal de Grande Instance of Paris issued its ruling onZELTIQ's and the Massachusetts General Hospital's (MGH) request for a permanentinjunction against Clinipro's LipoCryo based on LipoCryo's infringement of aEuropean patent owned by MGH and globally licensed exclusively to ZELTIQ whichis utilized in ZELTIQ's CoolSculpting(r) System. The Tribunal ruled that the MGHpatent is valid and enforceable and that Clinipro's LipoCryo infringes theclaims in the MGH patent. The Tribunal ordered Clinipro and its distributorsimmediately to stop selling, offering for sale, importing, distributing ormarketing LipoCryo in France thus removing the product from the market. Mark Foley, President and Chief Executive Officer said, 'We continue to take anaggressive and proactive approach in enforcing our CoolSculpting intellectualproperty and brand internationally and domestically. We are very pleased withthe Tribunal's decision which further validates CoolSculpting's strongintellectual property position. Our proprietary CoolSculpting system isspecifically engineered to monitor, deliver and maintain a precise coolingtemperature. Counterfeit systems, such as those manufactured by Clinipro, arelooking to profit on our pioneering and innovative technology with productsthat do not provide physicians and patients the safety and performance resultsthat they have come to expect. CoolSculpting continues to be the market leaderand is the only cold-based, non-surgical fat reduction and body contouringtreatment that is FDA-cleared. With over 550,000 procedures to date worldwide,we have unrivaled clinical experience in this area and will continue to seek toprotect our technology, physician practices, and patients from counterfeitproducts.' Mr. Foley added, 'As well, we continue to defend the investments in ourregistered CoolSculpting brand by aggressively pursuing those physicians thatblatantly violate our trademarks by marketing their practices as CoolSculptingcenters. We have been successful both domestically and internationally indefending our brand and will not tolerate unauthorized usage.' About ZELTIQ(r) Aesthetics, Inc.ZELTIQ is a medical technology company focused on developing andcommercializing products utilizing its proprietary controlled-coolingtechnology platform. ZELTIQ's first commercial product, the CoolSculptingSystem, is designed to selectively reduce stubborn fat that may not respond todiet or exercise. CoolSculpting is based on the scientific principle that fatcells are more sensitive to cold than the overlying skin and surroundingtissues. It utilizes patented technology of precisely controlled cooling toreduce the temperature of fat cells in the treated area, which is intended tocause fat cell elimination through a natural biological process known asapoptosis. ZELTIQ developed CoolSculpting to safely, noticeably and measurablyreduce the fat layer. CONTACT: INVESTOR RELATIONS: Patrick F. Williams ZELTIQ, Senior Vice President and CFO 925-474-2500 Nick Laudico / Rada Milenovici The Ruth Group for ZELTIQ 646-536-7030 / 7011 MEDIA CONTACT: Shari Gold GOLD PR for ZELTIQ 714-251-0375News Source: NASDAQ OMX28.05.2013 Dissemination of a Corporate News, transmitted by DGAP - a company of EquityStory AG.The issuer is solely responsible for the content of this announcement.DGAP's Distribution Services include Regulatory Announcements,Financial/Corporate News and Press Releases.Media archive at www.dgap-medientreff.de and www.dgap.de--------------------------------- Language: EnglishCompany: Zeltiq Aesthetics, Inc. United StatesPhone: Fax: E-mail: Internet: ISIN: US98933Q1085WKN: End of Announcement DGAP News-Service ---------------------------------


 

Breaking News


Kurs- und weitere Informationen zum Thema:

Zeltiq Aesthetics

Aktuelle Diskussionen zum Thema:

ZLTQ Zeltiq Aesthetics (WKN ... (13.02.17)

Aktuelle Nachrichten zum Unternehmen:


Alle Nachrichten zum Unternehmen

Aktuelle Analysen zu den Unternehmen:

Zeltiq Aesthetics
Weitere Meldungen
 
29.05 Directors' Dealings: Commerz.
29.05 Stimmrechtsanteile: Kabel De.
29.05 Directors' Dealings: ALNO A.
29.05 Directors' Dealings: ALNO A.
29.05 Directors' Dealings: Commerz.
29.05 Directors' Dealings: ALNO A.
29.05 Directors' Dealings: ALNO A.
29.05 Directors' Dealings: Commerz.
29.05 Stimmrechtsanteile: WCM Be.
29.05 Stimmrechtsanteile: Grammer.
29.05 CytoTools AG: Starke Betei.
29.05 Francotyp-Postalia Holding A.
29.05 AQUAMONDI Aktiengesellsc.
29.05 COR&FJA AG: COR&FJA .
29.05 Gold Resource Corporation e.
29.05 Euro Asia verkündet Wechs.
29.05 SMARTRAC meldet Inkraftt.
29.05 Zulassungsfolgepflichten: DZ.
29.05 Sberbank: Sberbank publishes.
29.05 Stimmrechtsanteile: PETROT.
29.05 FAST Casualwear: Gute Fin.
29.05 Sanochemia Pharmazeutika A.
29.05 Mutares AG: mutares schlie.
29.05 DF Deutsche Forfait AG sc.
29.05 ICA Publishes Its Multi-Medi.
29.05 CASSONA SE schließt das.
28.05 ZELTIQ Aesthetics Wins M.
28.05 Grand City Properties S.A.:.
28.05 Hauptversammlung der HOMA.
28.05 Stimmrechtsanteile: Deutsche.


Umfrage
 
Welche Social Networks nutzen Sie meistens?
Facebook
keine
Twitter
Xing
Linked in
Youtube
myspace
Google+
Wikipedia
andere


Stimmen: 40160 , Ergebnis


Kurssuche
Status: nicht eingeloggt

Registrieren | Passwort vergessen?
 
 
Im Bereich Nachrichten:
Die goldenen Regeln des Trading Teil 2!
Experte: Stefan Hofmann, STOCK-WORLD
Kolumnen
DOW JONES - Die Bullen ...
Philip Hopf, Hopf Klinkmüller Capital. (18.09.18)
Experte: Philip Hopf, Hopf Klinkmüller Capital Management K.
DAX mit zweifelhafter ...
CMC Markets, (18.09.18)
Experte: CMC Markets,
Gold/USD (spezial) ...
DONNER & REUSCHEL., (18.09.18)
Experte: DONNER & REUSCHEL AG,
DAX erstaunlich fest
Cornelia Frey, Börse Stuttgart AG (18.09.18)
Experte: Cornelia Frey, Börse Stuttgart AG
Nestlé: Warten auf den ...
S. Feuerstein, Hebelzertifikate-Trader (18.09.18)
Experte: S. Feuerstein, Hebelzertifikate-Trader
Ölpreis (WTI): Jetzt fällt ...
Robert Sasse, (18.09.18)
Experte: Robert Sasse,
De Grey Mining: Im Revier ...
Björn Junker, GOLDINVEST.de (18.09.18)
Experte: Björn Junker, GOLDINVEST.de
Bitcoin – Kursziel 3000?
Feingold-Research, (18.09.18)
Experte: Feingold-Research,
September-Rückkehrer
wikifolio.com, (18.09.18)
Experte: wikifolio.com,
S&P500 sollte bei 2.860 ...
Christian Zoller, www.boerse-daily.de (18.09.18)
Experte: Christian Zoller, www.boerse-daily.de
Exotic-Trader-Update: Allianz
Frank Sterzbach, www.boerse-daily.de (18.09.18)
Experte: Frank Sterzbach, www.boerse-daily.de
Silberpreis: Lassen Sie sich ...
Volker Gelfarth, (18.09.18)
Experte: Volker Gelfarth,
Niquet's World
Neues vom Portal
 
Das Problem der Kryptowährungen
Letzte Börsen-Meldung
 
Letzte Börsen-Analyse
 
Top-Klicks News
 
Top-Klicks Analysen